Condition: Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin · Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
The aim of this study is to compare the cost effectiveness of Sulfonylureas and DPP4-inhibitors in combination with Metformin among type2 diabetic patients diagnosed for 2-5 years. Glycemic status and other clinical outcome are compared in between two groups and ICER are compared.
This description comes directly from the study's public registry record.
Dr. Sheuly Akter, MD · +880-1951208001 · dr.sheuly7314@gmail.com
Md Sayedur Rahman, Professor · +880-197184757 · srkhasru@bsmmu.edu.bd
Always discuss trial participation with your own doctor first.
| BSMMU | Dhaka, Bangladesh | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06570980